Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03451513 · ClinicalTrials.gov registry record · NA
The Pride Body Project
A NA study, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 453
- Enrollment target
NCT03451513: Completed NA study, sponsored by San Diego State University.
NCT03451513 is a NA study that has completed, run by San Diego State University. The registered enrollment target is 453 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03451513, a NA study, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 453 participants
- Enrollment target
Study Summary
The purpose of this study is to better investigate the efficacy of the PRIDE Body Project in respect to preventing eating disorders in sexual minority men. In this randomized controlled trial, participants will be enrolled in one of two arms: 1) the PRIDE Body Project intervention or 2) Media Advocacy, a time and attention-matched intervention. This study will recruit participants who are between the ages of 18 and 35, identify as men, are gay, bisexual, or experience sexual attraction to men, and who express body image concerns for the San Diego area.
Primary Outcome
Assess changes in eating disorder symptoms and diagnosis
Interventions
- BEHAVIORAL Pride Body Project
- BEHAVIORAL Media Advocacy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 453 participants |
| Start Date | 2018-01-24 |
| Est. Completion | 2023-07-30 |
| Phase | NA |
What the finished NCT03451513 record still lists
NCT03451513 is an interventional study that assigns participants to a tested intervention. The registered 453 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which Pride Body Project is the first listed.
NCT03451513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03451513 about?
NCT03451513 is a clinical study titled "The Pride Body Project". The purpose of this study is to better investigate the efficacy of the PRIDE Body Project in respect to preventing eating disorders in sexual minority men. In this randomized controlled trial, participants will be enrolled in one of two arms: 1) the PRIDE Body Project intervention or 2) Media Advoca...
What is the current status of trial NCT03451513?
This trial is currently completed. It is a NA study. The enrollment target is 453 participants. The study started on 2018-01-24. Estimated completion is 2023-07-30.
What interventions are being tested in trial NCT03451513?
The interventions under investigation include: Pride Body Project (BEHAVIORAL), Media Advocacy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03451513?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03451513's enrollment target sits among peer trials
453 225th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI